TSXV approval REPLICEL LIFE SCIENCES INC. ("RP")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: October 26, 2022
TSX Venture Tier 1 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on March 21, 2022:
Number of Shares: 4,218,470 shares
Purchase Price: $0.18 per share
Warrants: 2,109,234 share purchase warrants to purchase 2,109,234 shares
Warrant Exercise Price: $0.40 for a three year period
Number of Placees: 2 placees
| Insider / Pro Group Participation: | | |
| | | |
| Placees | # of Placees | Aggregate # of Shares |
| | | |
| Aggregate Existing Insider Involvement: | 2 | 4,218,470 |
| Aggregate Pro Group Involvement: | N/A | N/A |
| | Aggregate Cash Amount | Aggregate # of Shares | Aggregate # of Warrants |
| Finder's Fee: | N/A | N/A | N/A |
The Company issued a news release on July 6, 2022, confirming closing of the private placement.